| Literature DB >> 23227234 |
Carolina Bonilla1, Debbie A Lawlor, Amy E Taylor, David J Gunnell, Yoav Ben-Shlomo, Andrew R Ness, Nicholas J Timpson, Beate St Pourcain, Susan M Ring, Pauline M Emmett, A David Smith, Helga Refsum, Craig E Pennell, Marie-Jo Brion, George Davey Smith, Sarah J Lewis.
Abstract
Vitamin B-12 is essential for the development and maintenance of a healthy nervous system. Brain development occurs primarily in utero and early infancy, but the role of maternal vitamin B-12 status during pregnancy on offspring cognitive function is unclear. In this study we assessed the effect of vitamin B-12 status in well-nourished pregnant women on the cognitive ability of their offspring in a UK birth cohort (ALSPAC). We then examined the association of SNPs in maternal genes FUT2 (rs492602) and TCN2 (rs1801198, rs9606756) that are related to plasma vitamin B-12, with offspring IQ. Observationally, there was a positive association between maternal vitamin B-12 intake and child's IQ that was markedly attenuated after adjustment for potential confounders (mean difference in offspring IQ score per doubling of maternal B-12 intake, before adjustment: 2.0 (95% CI 1.3, 2.8); after adjustment: 0.7 (95% CI -0.04, 1.4)). Maternal FUT2 was weakly associated with offspring IQ: mean difference in IQ per allele was 0.9 (95% CI 0.1, 1.6). The expected effect of maternal vitamin B-12 on offspring IQ, given the relationships between SNPs and vitamin B-12, and SNPs and IQ was consistent with the observational result. Our findings suggest that maternal vitamin B-12 may not have an important effect on offspring cognitive ability. However, further examination of this issue is warranted.Entities:
Mesh:
Substances:
Year: 2012 PMID: 23227234 PMCID: PMC3515553 DOI: 10.1371/journal.pone.0051084
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Figure 1Diagram showing the framework of the Mendelian randomization approach used in this study.
Figure 2Flow-diagram of participants in the study, and reasons for exclusions.
Characteristics of the study population.
| continuous variables | mean | SD | N |
| mother’s age at delivery (years) | 28.2 | 4.9 | 11678 |
| gestation at delivery (weeks) | 39.5 | 1.7 | 11678 |
| birth-weight (grams) | 3433.1 | 532.9 | 11530 |
| child’s age at testing (months) | 103.4 | 3.3 | 6371 |
| full scale IQ | 104.4 | 16.4 | 6259 |
| categorical variables | no. | % | N |
|
| 11144 | ||
| less than O level | 3290 | 29.5 | |
| O level | 3913 | 35.1 | |
| more than O level | 3941 | 35.4 | |
|
| 9160 | ||
| manual | 1815 | 19.8 | |
| non-manual | 7345 | 80.2 | |
|
| 11677 | ||
| male | 6027 | 51.6 | |
| female | 5650 | 48.4 | |
|
| 11169 | ||
| no children | 5017 | 44.9 | |
| 1 child | 3948 | 35.4 | |
| 2 children | 1581 | 14.2 | |
| 3 or more children | 623 | 5.6 | |
|
| 9684 | ||
| never | 2531 | 26.1 | |
| <3 months | 2208 | 22.8 | |
| 3–5 months | 1607 | 16.6 | |
| 6+ months | 3338 | 34.5 | |
|
| 10388 | ||
| no | 8079 | 77.8 | |
| yes | 2309 | 22.2 | |
|
| 11213 | ||
| no | 5589 | 49.8 | |
| yes | 5624 | 50.2 | |
|
| |||
|
| 11220 | ||
| never | 787 | 7.0 | |
| <1 glass per week | 4229 | 37.7 | |
| ≥1 glass per week | 4929 | 43.9 | |
| ≥1 glass per day | 1275 | 11.4 | |
|
| 11192 | ||
| never | 5000 | 44.7 | |
| <1 glass per week | 4412 | 39.4 | |
| ≥1 glass per week | 1582 | 14.1 | |
| ≥1 glass per day | 198 | 1.8 | |
|
| 11529 | ||
| no | 8232 | 71.4 | |
| yes | 3297 | 28.6 |
Association of maternal dietary vitamin B-12 intake during pregnancy with offspring IQ at age 8. N = 4787 with complete data on exposure, outcome and covariables in any model.
| mean difference in child IQ per doubling of maternal vitamin B-12 intake | 95% CI | p-value | |
| Model 1 | 2.0 | 1.3, 2.8 | <0.001 |
| Model 2 | 0.7 | −0.04, 1.4 | 0.06 |
| Model 3 | 0.5 | −0.2, 1.2 | 0.15 |
Model 1: Adjusted for offspring sex and age at time of IQ assessment, and maternal energy intake.
Model 2: As model 1 plus additional adjustment for potential confounding by maternal education, social class, age at delivery, parity, infection in pregnancy, ever smoked, alcohol consumption before and during pregnancy, and folate supplementation.
Model 3: As model 2 plus additional adjustment for potential mediation by gestational length, birth-weight and breastfeeding duration.
Association of maternal genotype at SNPs related to vitamin B-12 metabolism with maternal dietary intake at 32 weeks pregnant and vitamin B-12 cord blood concentration.
| SNP | genotype | N | median (IQR) of maternal vitaminB-12 dietary intake (µg/day) | N | median (IQR) of vitamin B-12 cord blood (pmol/L) |
|
| TT | 1642 | 4.2 (3.0, 6.1) | 62 | 291 (183, 397) |
| TC | 3187 | 4.2 (3.0, 6.1) | 128 | 300 (196, 424) | |
| CC | 1648 | 4.3 (3.0, 6.2) | 50 | 294 (214, 534) | |
| ratio of geometric means perC allele (95% CI) | 6477 | 1.00 (0.98, 1.02) | 240 | 1.08 (0.97, 1.19) | |
| p-value | 0.82/0.96 | 0.15/0.31 | |||
|
| GG | 1276 | 4.1 (3.0, 5.9) | 41 | 276 (173, 369) |
| CG | 3221 | 4.3 (3.2, 6.2) | 125 | 279 (196, 417) | |
| CC | 2002 | 4.1 (3.0, 6.1) | 68 | 318 (226, 436) | |
| ratio of geometric meansper C allele (95% CI) | 6499 | 1.01 (0.99, 1.03) | 234 | 1.13 (1.02–1.25) | |
| p-value | 0.44/0.02 | 0.02/0.07 | |||
|
| AA | 5483 | 4.3 (3.1, 6.2) | 193 | 288 (205, 397) |
| AG | 1650 | 4.3 (3.0, 6.1) | 58 | 298 (206, 484) | |
| GG | 120 | 4.0 (2.9, 6.1) | 2 | 238 (82, 394) | |
| ratio of geometric meansper G allele (95% CI) | 7253 | 0.99 (0.96, 1.01) | 253 | 1.03 (0.89, 1.18) | |
| p-value | 0.23/0.46 | 0.73/0.31 |
N reflects the number of mothers with genotype and dietary intake or offspring cord blood vitamin B-12 data, regardless of whether there was offspring IQ data available for them as well.
additive test/any effect test.
Association of maternal TCN2 haplotypes with vitamin B-12 cord blood levels and offspring IQ at age 8.
| rs9606756-rs1801198 haplotype | haplotype frequency | cord blood geometricmean (95% CI) | p-value | IQ mean (95% CI) | p-value |
| AC | 0.46 | 298 (274, 324) | 0.11 | 104.4 (103.7, 105.1) | 0.35 |
| AG | 0.41 | 278 (255, 304) | 0.02 | 104.1 (103.4, 104.7) | 0.03 |
| GC | 0.10 | 317 (257, 391) | 0.23 | 104.7 (103.4, 105.9) | 0.38 |
| GG | 0.03 | 279 (78, 995) | 0.85 | 108.6 (105.4, 111.8) | 0.01 |
|
| 0.14 | 0.01 | |||
|
| 5864 | 202 | 3429 |
p-value for testing the effect of each haplotype vs all others.
p-value for the omnibus test that compares the alternate model (each haplotype having a unique effect) vs the null model (no haplotypes having any effect).
N corresponds to the number of mothers with available genotype data for both SNPs (N = 5866), whose children had vitamin B-12 measured in cord blood (N = 202), or whose children had been IQ tested (N = 3429).
Association of maternal genotype at SNPs related to vitamin B-12 metabolism with offspring IQ at age 8.
| SNP | genotype | N | IQ mean (SD) |
|
| TT | 1009 | 103.3 (16.8) |
| TC | 1940 | 104.2 (16.1) | |
| CC | 1012 | 105.0 (16.7) | |
| mean difference in child IQ per Callele | 3961 | 0.86 (0.14, 1.58) | |
| p-value | 0.02 | ||
|
| GG | 784 | 103.9 (16.6) |
| CG | 1978 | 104.1 (16.0) | |
| CC | 1208 | 104.6 (17.0) | |
| mean difference in child IQ per Callele | 3970 | 0.35 (−0.38, 1.08) | |
| p-value | 0.35 | ||
|
| AA | 3673 | 104.5 (16.1) |
| AG | 1038 | 104.7 (17.0) | |
| GG | 74 | 108.0 (14.3) | |
| mean difference in child IQ per Gallele | 4785 | 0.55 (−0.44, 1.54) | |
| p-value | 0.28 |
Allele mentioned has been associated with higher vitamin B-12 or lower Hcy levels.